IP Library Granted Patent US 8,105,846
Granted Patent B2
US 8,105,846 · App. 12/093,610 · Granted Jan 31, 2012

Methods using pores

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,105,846
App. No.
12/093,610
Granted
Jan 31, 2012
Kind
B2
Abstract

The invention relates to a method of identifying an individual nucleotide, comprising (a) contacting the nucleotide with a transmembrane protein pore so that the nucleotide interacts with the pore and (b) measuring the current passing through the pore during the interaction and thereby determining the identity of the nucleotide. The invention also relates to a method of sequencing nucleic acid sequences and kits related thereto.

Claims (14)

1. A method of distinguishing an individual monophosphate nucleotide within a target sequence, comprising:

(a) digesting the target sequence to form the individual monophosphate nucleotide using a processive exonuclease;

(b) contacting the monophosphate nucleotide with a transmembrane protein pore so that the monophosphate nucleotide interacts with the pore, wherein the pore comprises a cyclodextrin that facilitates the interaction between the monophosphate nucleotide and the pore; and

(c) measuring a current passing through the pore during the interaction and thereby distinguishing the monophosphate nucleotide from other monophosphate nucleotides.

2. A method according to claim 1 , wherein the interaction involves the monophosphate nucleotide reversibly binding to the channel of the pore.

3. A method according to claim 1 , wherein the pore is α-hemolysin as shown in SEQ ID NO: 2 or a variant thereof.

4. A method according to claim 3 , wherein the variant is (M113R) 7 .

5. A method according to claim 1 , wherein the cyclodextrin is heptakis-6-amino-β-cyclodextrin (am 7 -β-CD).

6. A method according to claim 1 , wherein the individual monophosphate nucleotide is a ribonucleotide.

7. A method according to claim 1 , wherein the individual monophosphate nucleotide is a deoxyribonucleotide.

8. A method according to claim 1 , wherein more than one of the individual monophosphate nucleotides of the target sequence are contacted with the pore in a sequential manner such that the identity of the whole or part of the sequence may be determined.

9. The method of claim 1 , further comprising the step of:

(d) repeating steps (a) to (c) at an end of the target sequence and thereby determining the sequence of the target.

10. The method of claim 1 , wherein the processive exonuclease is covalently attached to the pore.

Assignments (2)
CHANGE OF NAME Recorded Aug 2, 2016
From: ISIS INNOVATION LIMITED
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 039550/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2008
From: BAYLEY, HAGAN; ASTIER, YANN; BRAHA, ORIT
To: ISIS INNOVATION LIMITED
Reel/Frame 021304/0902 →